Form D · Biotechnology

InspireMD Ltd.

Tel Aviv, L3 · CIK 0001498181

Offering snapshot reported Aug 6, 2010 · SEC filing

Reported sold
$1.58M
Offering amount: $1.58M
Investors reported
3
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 22, 2010
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 6, 2010Initial$1,580,000No comparison3SEC filing

Offering details

Securities
Debt, Option to acquire
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$63.2K
Finders' fees
$0
Form D file number
021-146006

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Palladium Capital Advisors LLC129400Palladium Capital Advisors LLC · CRD 129400

Source: Form D, filed Aug 6, 2010. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Eli Bar Director
Bob Fishel Director
Asher Holzer Director, Executive
David Ivry Director
Bary Oren Executive
Ofir Paz Director, Executive
Feliche Pelled Director
Eyal Weinstein Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
3 Menorat Hamaor St.
Tel Aviv, L3, 67448